Ceramide modulates HERG potassium channel gating by translocation into lipid rafts

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 1, 2010, Pages

  Ganapathi, Sindura B ^a   Fox, Todd E ^a   Kester, Mark ^a   Elmslie, Keith S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Activation kinetics; Cholesterol; Deactivation kinetics; Human ether go go related gene; Inhibition

Indexed keywords

CERAMIDE; POTASSIUM CHANNEL HERG;

ACTION POTENTIAL; ARTICLE; CELL MEMBRANE PERMEABILITY; CHANNEL GATING; CONTROLLED STUDY; DENSITOMETRY; DOSE RESPONSE; DRUG INHIBITION; ELECTRIC POTENTIAL; GENE TRANSLOCATION; HEART RHYTHM; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BETA-CYCLODEXTRINS; CAVEOLINS; CELL LINE; CERAMIDES; CHOLESTEROL; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; ION CHANNEL GATING; KINETICS; MEMBRANE MICRODOMAINS; MEMBRANE POTENTIALS; MODELS, BIOLOGICAL; POTASSIUM; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; TRANSFECTION;

ANIMALIA;

EID: 77953804784     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00462.2009     Document Type: Article

References (63)

1. Abi-Char J, Maguy A, Coulombe A, Balse E, Ratajczak P, Samuel JL, Nattel S, Hatem SN. Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes. J Physiol 582: 1205-1217, 2007.
2. Arcangeli A. Expression and role of hERG channels in cancer cells. Novartis Found Symp 266: 225-232, discussion 232-224, 2005.
3. Bai Y, Wang J, Shan H, Lu Y, Zhang Y, Luo X, Yang B, Wang Z. Sphingolipid metabolite ceramide causes metabolic perturbation contributing to HERG K+ channel dysfunction. Cell Physiol Biochem 20: 429-440, 2007.
4. Balijepalli RC, Delisle BP, Balijepalli SY, Foell JD, Slind JK, Kamp TJ, January CT. Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol. Channels (Austin) 1: 263-272, 2007.
5. Barbuti A, Gravante B, Riolfo M, Milanesi R, Terragni B, Di- Francesco D. Localization of pacemaker channels in lipid rafts regulates channel kinetics. Circ Res 94: 1325-1331, 2004.
6. Becchetti A, Arcangeli A. A comment on ion channels as pharmacological targets in oncology. J Gen Physiol 132: 313-314, 2008.
7. Berube J, Caouette D, Daleau P. Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line. J Pharmacol Exp Ther 297: 96-102, 2001. (Pubitemid 32242567)
8. Bianchi L, Wible B, Arcangeli A, Taglialatela M, Morra F, Castaldo P, Crociani O, Rosati B, Faravelli L, Olivotto M, Wanke E. herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 58: 815-822, 1998.
9. Bock J, Szabó I, Gamper N, Adams C, Gulbins E. Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms. Biochem Biophys Res Commun 305: 890-897, 2003.
10. Bourbon NA, Sandirasegarane L, Kester M. Ceramide-induced inhibition of Akt Is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem 277: 3286-3292, 2002.
11. Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275: 17221-17224, 2000.
12. Buraei Z, Schofield G, Elmslie KS. Roscovitine differentially affects CaV2 and Kv channels by binding to the open state. Neuropharmacology 52: 883-894, 2007.
13. Camacho J. Ether a go-go potassium channels and cancer. Cancer Lett 233: 1-9, 2006. (Pubitemid 43214557)
14. Casis O, Olesen SP, Sanguinetti MC. Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol 69: 658-665, 2006.
15. Chapman H, Ramstrom C, Korhonen L, Laine M, Wann KT, Lindholm D, Pasternack M, Tornquist K. Downregulation of the HERG (KCNH2) K+ channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation. J Cell Sci 118: 5325-5334, 2005.
16. Charles R, Sandirasegarane L, Yun J, Bourbon N, Wilson R, Rothstein RP, Levison SW, Kester M. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ Res 87: 282-288, 2000.
17. Chen SZ, Jiang M, Zhen YS. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. Cancer Chemother Pharmacol 56: 212-220, 2005.
18. Cherubini A, Taddei GL, Crociani O, Paglierani M, Buccoliero AM, Fontana L, Noci I, Borri P, Borrani E, Giachi M, Becchetti A, Rosati B, Wanke E, Olivotto M, Arcangeli A. HERG potassium channels are more frequently expressed in human endometrial cancer compared with non-cancerous endometrium. Br J Cancer 83: 1722-1729, 2000.
19. Elmslie KS, Werz MA, Overholt JL, Jones SW. Intracellular ATP and GTP are both required to preserve modulation of N-type calcium channel current by norepinephrine. Pflugers Arch 423: 472-479, 1993.
20. Fox TE, Houck KL, O'Neill SM, Nagarajan M, Stover TC, Pomianowski PT, Unal O, Yun JK, Naides SJ, Kester M. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J Biol Chem 282: 12450-12457, 2007.
21. Ganapathi SB, Kester M, Elmslie KS. State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy. Am J Physiol Cell Physiol 296: C701-C710, 2009.
22. Gulbins E, Kolesnick R. Measurement of sphingomyelinase activity. Methods Enzymol 322: 382-388, 2000.
23. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science 274: 1855-1859, 1996.
24. Hannun YA, Obeid LM. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277: 25847-25850, 2002.
25. Holopainen JM, Subramanian M, Kinnunen PK. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/ sphingomyelin membrane. Biochemistry 37: 17562-17570, 1998.
26. Kolesnick R. The therapeutic potential of modulating the ceramide/ sphingomyelin pathway. J Clin Invest 110: 3-8, 2002.
27. Lorenzo ED, Pillozzi S, Masselli M, Crociani O, Becchetti A, Arcangeli A. Potassium Channels as Novel Pharmacological Targets in Acute Myeloid Leukemia. Blood (ASH Annual Meeting Abstracts) 112, 2008.
28. Maguy A, Hebert TE, Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res 69: 798-807, 2006.
29. Martens JR, Navarro-Polanco R, Coppock EA, Nishiyama A, Parshley L, Grobaski TD, Tamkun MM. Differential targeting of shaker-like potassium channels to lipid rafts. J Biol Chem 275: 7443-7446, 2000.
30. Martens JR, O'Connell K, Tamkun M. Targeting of ion channels to membrane microdomains: localization of KV channels to lipid rafts. Trends Pharmacol Sci 25: 16-21, 2004. (Pubitemid 38076952)
31. Martens JR, Sakamoto N, Sullivan SA, Grobaski TD, Tamkun MM. Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 276: 8409-8414, 2001.
32. Masi A, Becchetti A, Restano-Cassulini R, Polvani S, Hofmann G, Buccoliero AM, Paglierani M, Pollo B, Taddei GL, Gallina P, Di Lorenzo N, Franceschetti S, Wanke E, Arcangeli A. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br J Cancer 93: 781-792, 2005.
33. Merrill AH Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 277: 25843-25846, 2002.
34. Modrak DE. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy. Methods Mol Med 111: 183-194, 2005.
35. Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stühmer W. Role of voltage-gated potassium channels in cancer. J Membr Biol 205: 115-124, 2005.
36. Pillozzi S, Brizzi MF, Balzi M, Crociani O, Cherubini A, Guasti L, Bartolozzi B, Becchetti A, Wanke E, Bernabei PA, Olivotto M, Pegoraro L, Arcangeli A. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 16: 1791-1798, 2002.
37. Pillozzi S, Brizzi MF, Bernabei PA, Bartolozzi B, Caporale R, Basile V, Boddi V, Pegoraro L, Becchetti A, Arcangeli A. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 110: 1238-1250, 2007.
38. Pottosin II, Valencia-Cruz G, Bonales-Alatorre E, Shabala SN, Dobrovinskaya OR. Methyl-beta-cyclodextrin reversibly alters the gating of lipid rafts-associated Kv1.3 channels in Jurkat T lymphocytes. Pflugers Arch 454: 235-244, 2007.
39. Pusch M, Neher E. Rates of diffusional exchange between small cells and a measuring patch pipette. Pflugers Arch 411: 204-211, 1988. (Pubitemid 18066967)
40. Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 272: 21388-21395, 1997.
41. Romanelli RJ, LeBeau AP, Fulmer CG, Lazzarino DA, Hochberg A, Wood TL. Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. J Biol Chem 282: 22513-22524, 2007.
42. Roy M, Dumaine R, Brown AM. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94: 817-823, 1996. (Pubitemid 26289240)
43. Saddoughi SA, Song P, Ogretmen B. Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 49: 413-440, 2008.
44. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81: 299-307, 1995.
45. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 440: 463-469, 2006.
46. Schwarz JR, Bauer CK. Functions of erg K+ channels in excitable cells. J Cell Mol Med 8: 22-30, 2004.
47. Shayman JA, Abe A, Hiraoka M. A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity. Glycoconj J 20: 25-32, 2004.
48. Shibasaki T. Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart. J Physiol 387: 227-250, 1987. (Pubitemid 17099361)
49. Song KS, Li Shengwen, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271: 9690-9697, 1996. (Pubitemid 126552368)
50. Stover T, Kester M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 307: 468-475, 2003.
51. Stover TC, Sharma A, Robertson GP, Kester M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 11: 3465-3474, 2005.
52. Tikku S, Epshtein Y, Collins H, Travis AJ, Rothblat GH, Levitan I. Relationship between Kir2.1/Kir2.3 activity and their distributions between cholesterol-rich and cholesterol-poor membrane domains. Am J Physiol Cell Physiol 293: C440-C450, 2007.
53. Vandenberg JI, Walker BD, Campbell TJ. HERG K+ channels: friend and foe. Trends Pharmacol Sci 22: 240-246, 2001.
54. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N, Wong PC, Xu H, Thinakaran G. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 279: 44945-44954, 2004.
55. Wadhwa S, Wadhwa P, Dinda AK, Gupta NP. Differential expression of potassium ion channels in human renal cell carcinoma. Int Urol Nephrol 41: 251-257, 2009.
56. Wang S, Liu S, Morales MJ, Strauss HC, Rasmusson RL. A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes. J Physiol 502: 45-60, 1997.
57. Wonderlin WF, Strobl JS. Potassium channels, proliferation and G1 progression. J Membr Biol 154: 91-107, 1996.
58. Wong W, Schlichter LC. Differential recruitment of Kv1.4 and Kv4.2 to lipid rafts by PSD-95. J Biol Chem 279: 444-452, 2004.
59. Wyatt DL, de Godoy CM, Cukierman S. Enhancement of proton transfer in ion channels by membrane phosphate headgroups. J Phys Chem B 113: 6725-6731, 2009.
60. Yarbrough TL, Lu T, Lee HC, Shibata EF. Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res 90: 443-449, 2002.
61. Zhang S, Kehl SJ, Fedida D. Modulation of human ether-à-go-go- related K+ (HERG) channel inactivation by Cs+ and K+. J Physiol 548: 691-702, 2003.
62. Zhou Z, Gong Q, Epstein ML, January CT. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem 273: 21061-21066, 1998.
63. Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74: 230-241, 1998.